CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease — Stella

Recruiting

Back to Systemic Lupus Erythematosus trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Germany

Universitätsklinikum Erlangen, Erlangen, Bavaria

Key details

Phase

Early testing / Safety & dosing

Sponsor

Miltenyi Biomedicine GmbH

Enrollment target

~24 participants

Started

July 2023

Primary completion

May 2026

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov